David Drutz - Jun 15, 2022 Form 4 Insider Report for Altimmune, Inc. (ALT)

Role
Director
Signature
/s/Richard Eisenstadt, as Attorney-in-Fact
Stock symbol
ALT
Transactions as of
Jun 15, 2022
Transactions value $
$8,000
Form type
4
Date filed
6/16/2022, 09:27 PM
Previous filing
May 25, 2022
Next filing
Sep 30, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALT Common Stock, par value $0.0001 Purchase $8K +1K +5.26% $8.00 20K Jun 15, 2022 Direct
holding ALT Common Stock, par value $0.0001 333 Jun 15, 2022 See Footnote F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents Common Stock held by Pacific Biopharma Associates, LLC, of which the reporting person is the President.